Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016090580> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W2016090580 endingPage "274" @default.
- W2016090580 startingPage "269" @default.
- W2016090580 abstract "Tay-Sachs and Sandhoff diseases (GM2 gangliosidoses) are autosomal recessive lysosomal storage diseases caused by gene mutations in HEXA and HEXB, each encoding human lysosomal β-hexosaminidase α-subunits and β-subunits, respectively. In Tay-Sachs disease, excessive accumulation of GM2 ganglioside (GM2), mainly in the central nervous system, is caused by a deficiency of the HexA isozyme (αβ heterodimer), resulting in progressive neurologic disorders. In Sandhoff disease, combined deficiencies of HexA and HexB (ββ homodimer) cause not only the accumulation of GM2 but also of oligosaccharides carrying terminal N-acetylhexosamine residues (GlcNAc-oligosaccharides), resulting in systemic manifestations including hepatosplenomegaly as well as neurologic symptoms. Hence there is little clinically effective treatment for these GM2 gangliosidoses. Recent studies on the molecular pathogenesis in Sandhoff disease patients and disease model mice have shown the involvement of microglial activation and chemokine induction in neuroinflammation and neurodegeneration in this disease. Experimental and therapeutic approaches, including recombinant enzyme replacement, have been performed using Sandhoff disease model mice, suggesting the future application of novel techniques to treat GM2 gangliosidoses (Hex deficiencies), including Sandhoff disease as well as Tay-Sachs disease. In this study, we isolated astrocytes and microglia from the neonatal brain of Sandhoff disease model mice and demonstrated abnormalities of glial cells. Moreover, we demonstrated the therapeutic effect of an intracerebroventricular administration of novel recombinant human HexA carrying a high content of M6P residue in Sandhoff disease model mice." @default.
- W2016090580 created "2016-06-24" @default.
- W2016090580 creator A5027842743 @default.
- W2016090580 date "2013-02-01" @default.
- W2016090580 modified "2023-10-14" @default.
- W2016090580 title "Molecular Pathogenesis and Therapeutic Approach of GM2 Gangliosidosis" @default.
- W2016090580 cites W2023641192 @default.
- W2016090580 cites W2026186263 @default.
- W2016090580 cites W2027065209 @default.
- W2016090580 cites W2042512150 @default.
- W2016090580 cites W2043642541 @default.
- W2016090580 cites W2120914981 @default.
- W2016090580 cites W2313827278 @default.
- W2016090580 doi "https://doi.org/10.1248/yakushi.12-00199" @default.
- W2016090580 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23370522" @default.
- W2016090580 hasPublicationYear "2013" @default.
- W2016090580 type Work @default.
- W2016090580 sameAs 2016090580 @default.
- W2016090580 citedByCount "3" @default.
- W2016090580 countsByYear W20160905802019 @default.
- W2016090580 countsByYear W20160905802020 @default.
- W2016090580 crossrefType "journal-article" @default.
- W2016090580 hasAuthorship W2016090580A5027842743 @default.
- W2016090580 hasBestOaLocation W20160905801 @default.
- W2016090580 hasConcept C111204789 @default.
- W2016090580 hasConcept C126322002 @default.
- W2016090580 hasConcept C181199279 @default.
- W2016090580 hasConcept C203014093 @default.
- W2016090580 hasConcept C2776925932 @default.
- W2016090580 hasConcept C2777878887 @default.
- W2016090580 hasConcept C2778098279 @default.
- W2016090580 hasConcept C2778264360 @default.
- W2016090580 hasConcept C2779134260 @default.
- W2016090580 hasConcept C2779390119 @default.
- W2016090580 hasConcept C55493867 @default.
- W2016090580 hasConcept C71924100 @default.
- W2016090580 hasConcept C86803240 @default.
- W2016090580 hasConcept C97343561 @default.
- W2016090580 hasConceptScore W2016090580C111204789 @default.
- W2016090580 hasConceptScore W2016090580C126322002 @default.
- W2016090580 hasConceptScore W2016090580C181199279 @default.
- W2016090580 hasConceptScore W2016090580C203014093 @default.
- W2016090580 hasConceptScore W2016090580C2776925932 @default.
- W2016090580 hasConceptScore W2016090580C2777878887 @default.
- W2016090580 hasConceptScore W2016090580C2778098279 @default.
- W2016090580 hasConceptScore W2016090580C2778264360 @default.
- W2016090580 hasConceptScore W2016090580C2779134260 @default.
- W2016090580 hasConceptScore W2016090580C2779390119 @default.
- W2016090580 hasConceptScore W2016090580C55493867 @default.
- W2016090580 hasConceptScore W2016090580C71924100 @default.
- W2016090580 hasConceptScore W2016090580C86803240 @default.
- W2016090580 hasConceptScore W2016090580C97343561 @default.
- W2016090580 hasIssue "2" @default.
- W2016090580 hasLocation W20160905801 @default.
- W2016090580 hasLocation W20160905802 @default.
- W2016090580 hasOpenAccess W2016090580 @default.
- W2016090580 hasPrimaryLocation W20160905801 @default.
- W2016090580 hasRelatedWork W2016090580 @default.
- W2016090580 hasRelatedWork W2023641192 @default.
- W2016090580 hasRelatedWork W2038124013 @default.
- W2016090580 hasRelatedWork W2044970570 @default.
- W2016090580 hasRelatedWork W2099717197 @default.
- W2016090580 hasRelatedWork W2400001500 @default.
- W2016090580 hasRelatedWork W2413586008 @default.
- W2016090580 hasRelatedWork W2767492078 @default.
- W2016090580 hasRelatedWork W3163785018 @default.
- W2016090580 hasRelatedWork W4312143566 @default.
- W2016090580 hasVolume "133" @default.
- W2016090580 isParatext "false" @default.
- W2016090580 isRetracted "false" @default.
- W2016090580 magId "2016090580" @default.
- W2016090580 workType "article" @default.